Titre : Politique publique

Politique publique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Polysomnography
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Politique publique : Questions médicales les plus fréquentes", "headline": "Politique publique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Politique publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Politique publique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Politiques de régulation sociale", "url": "https://questionsmedicales.fr/mesh/D011049", "about": { "@type": "MedicalCondition", "name": "Politiques de régulation sociale", "code": { "@type": "MedicalCode", "code": "D011049", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Politique de planification familiale", "alternateName": "Family Planning Policy", "url": "https://questionsmedicales.fr/mesh/D016656", "about": { "@type": "MedicalCondition", "name": "Politique de planification familiale", "code": { "@type": "MedicalCode", "code": "D016656", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.214" } } }, { "@type": "MedicalWebPage", "name": "Politique de santé", "alternateName": "Health Policy", "url": "https://questionsmedicales.fr/mesh/D006291", "about": { "@type": "MedicalCondition", "name": "Politique de santé", "code": { "@type": "MedicalCode", "code": "D006291", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Politique nutritionnelle", "alternateName": "Nutrition Policy", "url": "https://questionsmedicales.fr/mesh/D018673", "about": { "@type": "MedicalCondition", "name": "Politique nutritionnelle", "code": { "@type": "MedicalCode", "code": "D018673", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.650" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Apports nutritionnels recommandés", "alternateName": "Recommended Dietary Allowances", "url": "https://questionsmedicales.fr/mesh/D064167", "about": { "@type": "MedicalCondition", "name": "Apports nutritionnels recommandés", "code": { "@type": "MedicalCode", "code": "D064167", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.650.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Apports nutritionnels recommandés", "alternateName": "Recommended Dietary Allowances", "url": "https://questionsmedicales.fr/mesh/D064167", "about": { "@type": "MedicalCondition", "name": "Apports nutritionnels recommandés", "code": { "@type": "MedicalCode", "code": "D064167", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.650.500" } } }, { "@type": "MedicalWebPage", "name": "Contrôle du tabac", "alternateName": "Tobacco Control", "url": "https://questionsmedicales.fr/mesh/D000092843", "about": { "@type": "MedicalCondition", "name": "Contrôle du tabac", "code": { "@type": "MedicalCode", "code": "D000092843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.825" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Politique anti-tabac", "alternateName": "Smoke-Free Policy", "url": "https://questionsmedicales.fr/mesh/D061845", "about": { "@type": "MedicalCondition", "name": "Politique anti-tabac", "code": { "@type": "MedicalCode", "code": "D061845", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.825.500" } } }, { "@type": "MedicalWebPage", "name": "Prévention du fait de fumer", "alternateName": "Smoking Prevention", "url": "https://questionsmedicales.fr/mesh/D000074606", "about": { "@type": "MedicalCondition", "name": "Prévention du fait de fumer", "code": { "@type": "MedicalCode", "code": "D000074606", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.825.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Politique anti-tabac", "alternateName": "Smoke-Free Policy", "url": "https://questionsmedicales.fr/mesh/D061845", "about": { "@type": "MedicalCondition", "name": "Politique anti-tabac", "code": { "@type": "MedicalCode", "code": "D061845", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.825.500" } } }, { "@type": "MedicalWebPage", "name": "Prévention du fait de fumer", "alternateName": "Smoking Prevention", "url": "https://questionsmedicales.fr/mesh/D000074606", "about": { "@type": "MedicalCondition", "name": "Prévention du fait de fumer", "code": { "@type": "MedicalCode", "code": "D000074606", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.623.500.608.428.825.750" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Politique publique", "alternateName": "Public Policy", "code": { "@type": "MedicalCode", "code": "D011640", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Krystyna Kongats", "url": "https://questionsmedicales.fr/author/Krystyna%20Kongats", "affiliation": { "@type": "Organization", "name": "School of Public Health, University of Alberta, Edmonton Clinic Health Academy, Edmonton, Alberta, Canada." } }, { "@type": "Person", "name": "Jennifer Ann McGetrick", "url": "https://questionsmedicales.fr/author/Jennifer%20Ann%20McGetrick", "affiliation": { "@type": "Organization", "name": "School of Public Health, University of Alberta, Edmonton Clinic Health Academy, Edmonton, Alberta, Canada." } }, { "@type": "Person", "name": "Kim D Raine", "url": "https://questionsmedicales.fr/author/Kim%20D%20Raine", "affiliation": { "@type": "Organization", "name": "School of Public Health, University of Alberta, Edmonton Clinic Health Academy, Edmonton, Alberta, Canada." } }, { "@type": "Person", "name": "Sonja Grelle", "url": "https://questionsmedicales.fr/author/Sonja%20Grelle", "affiliation": { "@type": "Organization", "name": "Faculty of Psychology, Ruhr University Bochum." } }, { "@type": "Person", "name": "Wilhelm Hofmann", "url": "https://questionsmedicales.fr/author/Wilhelm%20Hofmann", "affiliation": { "@type": "Organization", "name": "Faculty of Psychology, Ruhr University Bochum." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Assessing sleep in children with Down syndrome: Comparison of parental sleep diaries, actigraphy and polysomnography.", "datePublished": "2023-05-18", "url": "https://questionsmedicales.fr/article/37271108", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2023.05.003" } }, { "@type": "ScholarlyArticle", "name": "Objective polysomnography-based sleep features and major depressive disorder subtypes in the general population.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37098299", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psychres.2023.115213" } }, { "@type": "ScholarlyArticle", "name": "Comparison of a home sleep test with in-laboratory polysomnography in the diagnosis of obstructive sleep apnea syndrome.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35507020", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/JCMA.0000000000000741" } }, { "@type": "ScholarlyArticle", "name": "Lost to follow-up: Post-operative polysomnography in at-risk, pediatric obstructive sleep apnea.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37187142", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijporl.2023.111581" } }, { "@type": "ScholarlyArticle", "name": "Can polysomnography be replaced by ApneaGraph200 for OSA diagnosis? A protocol for systematic review and meta-analysis.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36576531", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00405-022-07815-8" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Organisations et économie des soins de santé", "item": "https://questionsmedicales.fr/mesh/D004472" }, { "@type": "ListItem", "position": 3, "name": "Politique (principe)", "item": "https://questionsmedicales.fr/mesh/D057766" }, { "@type": "ListItem", "position": 4, "name": "Politiques de régulation sociale", "item": "https://questionsmedicales.fr/mesh/D011049" }, { "@type": "ListItem", "position": 5, "name": "Politique publique", "item": "https://questionsmedicales.fr/mesh/D011640" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Politique publique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Politique publique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Politique publique", "description": "Comment évaluer l'impact d'une politique publique en santé ?\nQuels outils sont utilisés pour le diagnostic des politiques ?\nQuelles sont les méthodes d'analyse des politiques publiques ?\nComment identifier les besoins de santé dans une communauté ?\nQuel rôle joue la recherche dans le diagnostic des politiques ?", "url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Polysomnography&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Politique publique", "description": "Quels symptômes indiquent un échec de la politique publique ?\nComment mesurer les symptômes de l'inefficacité des politiques ?\nQuels indicateurs de santé révèlent des problèmes systémiques ?\nComment les symptômes sociaux affectent-ils la santé publique ?\nQuels symptômes peuvent signaler un besoin de réforme ?", "url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Polysomnography&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Politique publique", "description": "Quelles stratégies de prévention sont efficaces en politique publique ?\nComment évaluer l'efficacité des programmes de prévention ?\nQuels obstacles à la prévention sont souvent rencontrés ?\nComment les politiques publiques peuvent-elles promouvoir la prévention ?\nQuel rôle joue l'éducation dans la prévention des maladies ?", "url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Polysomnography&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Politique publique", "description": "Comment les politiques influencent-elles les traitements disponibles ?\nQuels traitements sont souvent négligés par les politiques publiques ?\nComment évaluer l'efficacité des traitements en politique publique ?\nQuel est l'impact des politiques sur les traitements préventifs ?\nComment les politiques de santé affectent-elles les traitements psychologiques ?", "url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Polysomnography&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Politique publique", "description": "Quelles complications peuvent résulter d'une mauvaise politique de santé ?\nComment les complications de santé sont-elles liées aux politiques publiques ?\nQuels sont les effets à long terme d'une politique de santé défaillante ?\nComment prévenir les complications liées aux politiques de santé ?\nQuel rôle jouent les données dans la prévention des complications ?", "url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Polysomnography&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Politique publique", "description": "Quels facteurs de risque sont souvent négligés par les politiques ?\nComment les politiques peuvent-elles réduire les facteurs de risque ?\nQuel impact a l'environnement sur les facteurs de risque ?\nComment les politiques de santé abordent-elles les facteurs de risque ?\nQuels sont les facteurs de risque liés aux comportements ?", "url": "https://questionsmedicales.fr/mesh/D011640?mesh_terms=Polysomnography&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'impact d'une politique publique en santé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'impact se mesure par des indicateurs de santé, des études d'impact et des analyses de données." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour le diagnostic des politiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des enquêtes, des analyses statistiques et des études de cas sont couramment utilisés." } }, { "@type": "Question", "name": "Quelles sont les méthodes d'analyse des politiques publiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les méthodes incluent l'analyse qualitative, quantitative et l'analyse coût-bénéfice." } }, { "@type": "Question", "name": "Comment identifier les besoins de santé dans une communauté ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des enquêtes, des focus groups et l'analyse des données de santé existantes." } }, { "@type": "Question", "name": "Quel rôle joue la recherche dans le diagnostic des politiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La recherche fournit des données probantes pour orienter les décisions politiques et évaluer l'efficacité." } }, { "@type": "Question", "name": "Quels symptômes indiquent un échec de la politique publique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des inégalités de santé croissantes et une augmentation des maladies évitables peuvent indiquer un échec." } }, { "@type": "Question", "name": "Comment mesurer les symptômes de l'inefficacité des politiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "En analysant les taux de morbidité, mortalité et l'accès aux soins de santé." } }, { "@type": "Question", "name": "Quels indicateurs de santé révèlent des problèmes systémiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les taux de vaccination, d'obésité et de maladies chroniques sont des indicateurs clés." } }, { "@type": "Question", "name": "Comment les symptômes sociaux affectent-ils la santé publique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des problèmes comme la pauvreté et le chômage aggravent les conditions de santé et l'accès aux soins." } }, { "@type": "Question", "name": "Quels symptômes peuvent signaler un besoin de réforme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une hausse des plaintes des citoyens et des résultats de santé dégradés peuvent signaler ce besoin." } }, { "@type": "Question", "name": "Quelles stratégies de prévention sont efficaces en politique publique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les campagnes de sensibilisation, les programmes de vaccination et l'éducation à la santé." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des programmes de prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Par des études d'impact, des indicateurs de santé et des analyses de coûts." } }, { "@type": "Question", "name": "Quels obstacles à la prévention sont souvent rencontrés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le manque de financement, l'accès limité aux soins et la désinformation sont des obstacles majeurs." } }, { "@type": "Question", "name": "Comment les politiques publiques peuvent-elles promouvoir la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "En intégrant des programmes de prévention dans les systèmes de santé et en finançant des initiatives." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation dans la prévention des maladies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation sensibilise la population aux comportements sains et aux risques de maladies." } }, { "@type": "Question", "name": "Comment les politiques influencent-elles les traitements disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les politiques déterminent le financement, l'accès et les protocoles de traitement en santé." } }, { "@type": "Question", "name": "Quels traitements sont souvent négligés par les politiques publiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements pour les maladies rares et les soins palliatifs sont souvent sous-financés." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des traitements en politique publique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Par des études cliniques, des revues systématiques et des analyses de coût-efficacité." } }, { "@type": "Question", "name": "Quel est l'impact des politiques sur les traitements préventifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les politiques favorisent l'accès aux vaccinations et dépistages, réduisant ainsi les maladies." } }, { "@type": "Question", "name": "Comment les politiques de santé affectent-elles les traitements psychologiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles influencent le financement et l'accès aux soins de santé mentale, souvent négligés." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter d'une mauvaise politique de santé ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des inégalités de santé, une augmentation des maladies chroniques et un accès limité aux soins." } }, { "@type": "Question", "name": "Comment les complications de santé sont-elles liées aux politiques publiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des politiques inefficaces peuvent aggraver les conditions de santé et limiter l'accès aux traitements." } }, { "@type": "Question", "name": "Quels sont les effets à long terme d'une politique de santé défaillante ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une augmentation des coûts de santé, une détérioration de la santé publique et des inégalités croissantes." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux politiques de santé ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En évaluant régulièrement les politiques et en adaptant les programmes aux besoins de la population." } }, { "@type": "Question", "name": "Quel rôle jouent les données dans la prévention des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les données aident à identifier les problèmes, à évaluer les politiques et à orienter les interventions." } }, { "@type": "Question", "name": "Quels facteurs de risque sont souvent négligés par les politiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les déterminants sociaux de la santé, comme la pauvreté et l'éducation, sont souvent sous-estimés." } }, { "@type": "Question", "name": "Comment les politiques peuvent-elles réduire les facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "En promouvant des environnements sains, l'éducation et l'accès aux soins préventifs." } }, { "@type": "Question", "name": "Quel impact a l'environnement sur les facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement pollué ou peu sûr augmente les risques de maladies et affecte la santé publique." } }, { "@type": "Question", "name": "Comment les politiques de santé abordent-elles les facteurs de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Elles intègrent des stratégies de prévention et d'éducation pour réduire les risques de maladies." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque liés aux comportements ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'alimentation malsaine et le manque d'activité physique sont des facteurs clés." } } ] } ] }

Sources (822 au total)

Assessing sleep in children with Down syndrome: Comparison of parental sleep diaries, actigraphy and polysomnography.

This study compared measurements of sleep and wake assessed with actigraphy, sleep diary and polysomnography in children with Down syndrome (DS) and also compared measures of actigraphic sleep recordi... Children with DS aged 3-19 years (N = 44) referred for assessment of sleep disordered breathing (SDB) underwent overnight polysomnography, together with 1 week of actigraphy with sleep diary. Actigrap... 22 children (50%) with DS completed >3 consecutive nights of actigraphy with a matched sleep diary. There were no differences between bedtimes, wake times or time in bed on weeknights, weekends or ove... Parental sleep diaries over-estimate total sleep time but accurately report bed and wake times compared to actigraphy in children with DS. Children with DS have more regular sleep patterns than TD chi...

Comparison of a home sleep test with in-laboratory polysomnography in the diagnosis of obstructive sleep apnea syndrome.

In-laboratory, polysomnography (PSG) is the gold standard for diagnosing obstructive sleep apnea syndrome (OSAS). However, the long waiting list and sleeping at a hospital make patients hesitate to un... This retrospective study included 67 patients with clinically suspected OSAS. All patients were allocated to receive both PSG and the HST. The apnea-hypopnea index (AHI) measured through PSG was used ... Among the 67 patients, no significant difference was noted in the average AHI values obtained using PSG and the HST ( p = 0.103). The AHI obtained from HST was significantly correlated with that obtai... The HST used in preliminary screening of patients with suspected OSAS achieved an accuracy of >90%. For patients with moderate to severe OSAS, the accuracy was below 80%. Therefore, for patients who r...

Lost to follow-up: Post-operative polysomnography in at-risk, pediatric obstructive sleep apnea.

Analyze adherence to AASM recommendations for post-operative polysomnography in eligible pediatric patients.... Retrospective Cohort.... Tertiary, Outpatient Sleep Lab.... We conducted a retrospective analysis of pediatric patients, ages 1-17, previously diagnosed with moderate-severe obstructive sleep apnea that completed a surgical intervention. Chart review included ... Of the 373 patients, 67 patients met inclusion criteria. Fifty-nine followed-up with any provider, with 21 completing post-operative polysomnography. Patients with residual or recurrent symptoms (p < ... Recurrent symptoms and increasing disease severity were associated with obtaining post-operative polysomnography. However, variability existed for which patients completed post-operative polysomnograp...

Can polysomnography be replaced by ApneaGraph200 for OSA diagnosis? A protocol for systematic review and meta-analysis.

It is yet unknown if the ApneaGraph200 system can replace the Polysomnography system (PSG), which is now the gold standard for obstructive sleep apnea (OSA) diagnosis. We performed a meta-analysis to ... Utilizing PubMed, Elsevier, Wanfang, and China National Knowledge Internet (CNKI), a thorough literature search was carried out. Eligible studies contrasting the AG200 system and the PSG system were f... The meta-analysis A pooled the comparison of AHI between the AG and PSG groups, and included seven studies involving a total of 419 participants, which revealed that there was a significant difference... The ApneaGraph200 system can be used for the initial screening of OSA patients, but it is not a complete alternative to polysomnography for the diagnosis and severity of the OSA condition....

Comparison of polysomnography in people with Alzheimer's disease and insomnia versus non-demented elderly people with insomnia.

We used baseline polysomnography (PSG) data obtained during the clinical program development for suvorexant to compare the PSG profiles of people with Alzheimer's disease and insomnia (ADI) versus age... Sleep laboratory baseline PSG data from participants age 55-80 years from 2 trials in people with insomnia and a trial in people with ADI were included. ADI participants had dementia of mild-to-modera... A total of 837 EI and 239 ADI participants were included, with the majority in each population (∼65%) being women. Compared to EI, those with ADI had a lower percentage of time spent in slow wave slee... Our findings in this large data set, in which the influence of sleep problems was effectively subtracted out (since both groups had insomnia), provide strong confirmatory support of results from previ... ClinicalTrials.gov, numbers NCT01097616, NCT01097629, NCT02750306....

Nasal cannula use during polysomnography in children aged under three with suspected sleep apnea.

Early diagnosis of obstructive sleep apnea (OSA) in children is important. The use of a nasal cannula as an airflow sensor during polysomnography has not been evaluated in younger children. The study ... A total of 185 patients were prospectively included. Respiratory events were scored using nasal cannula alone, thermistor alone, and both methods simultaneously as the airflow sensor. Agreement and di... One hundred and seventy-two children were finally analyzed and 110 (64.0%) presented OSA. Total sleep time with an uninterpretable signal was longer with the nasal cannula than with the thermistor (17... In children under the age of three, the ability of the nasal cannula to detect obstructive events was relatively low. Therefore, other non-invasive measurements for identifying respiratory events duri...

Night-to-Night Variability of Polysomnography-Derived Physiologic Endotypic Traits in Patients With Moderate to Severe OSA.

Emerging data suggest that determination of physiologic endotypic traits (eg, loop gain) may enable precision medicine in OSA.... Does a single-night assessment of polysomnography-derived endotypic traits provide reliable estimates in moderate to severe OSA?... Two consecutive in-lab polysomnography tests from a clinical trial (n = 67; male, 69%; mean ± SD age, 61 ± 10 years; apnea-hypopnea index [AHI] 53 ± 22 events/h) were used for the reliability analysis... Reliability of endotypic traits between the two consecutive nights was moderate to good (ICC: V... Endotypic trait analysis using a single standard polysomnography shows acceptable reliability and reproducibility in patients with moderate to severe OSA. The reported MDDs of endotypic traits may fac...